Crinetics Pharmaceuticals Inc Earnings logo

CRNX

Crinetics Pharmaceuticals Inc Earnings

$53.66

Earnings Summary

Revenue
$0Mn
Net Profits
$-76.83Mn
Net Profit Margins
-Inf%
Highlights
Revenue:

Crinetics Pharmaceuticals Inc’s revenue fell -100% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -100% fall in its revenue since last 3-months.

Net Profits:

Crinetics Pharmaceuticals Inc’s net profit fell -33.71% since last year same period to $-76.83Mn in the Q3 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -3.74% fall in its net profits since last 3-months.

Net Profit Margins:

Crinetics Pharmaceuticals Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -Inf% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Crinetics Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter
-0.91
EPS Estimate Current Year
-0.91
Highlights
EPS Estimate Current Quarter:

Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.91 - a -5.81% fall from last quarter’s estimates.

EPS Estimate Current Year:

Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.91.

Key Ratios

Key ratios of the Crinetics Pharmaceuticals Inc post its Q3 2024 earnings
Earning Per Share (EPS)
-0.96
Highlights
Earning Per Share (EPS):

Crinetics Pharmaceuticals Inc’s earning per share (EPS) jumped 4.95% since last year same period to -0.96 in the Q3 2024. This indicates that the Crinetics Pharmaceuticals Inc has generated 4.95% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-11-12
-0.91
-0.96
-5.49%
2024-05-09
-0.81
-0.93
-14.81%
2024-08-08
-0.86
-0.94
-9.3%